Oxidation and other chemical degradation: BPC-157 does not contain cysteine, the most oxidation-sensitive residue in many peptides, so the dominant oxidative risk is lower than for cysteine-containing sequences
We noted in the CY 2026 OPPS/ASC proposed rule that based on the description the applicant provided, the Axoguard HA+ Nerve Protector TM is a porcine SIS ECM with hyaluronate-alginate coating used for the management and protection of peripheral nerve injuries where there is no gap or following closure of a gap, and thus, could be encompassed by the descriptors C1763 and C1765
If administered by injection, local reactions such as redness, swelling, itching, or pain can occur, and improper technique can increase infection risk
Two weeks at the lowest effective dose reveals individual sensitivity
We ensure safe, medical-grade sourcing and precise dosing for optimal results